Arcturus Therapeutics is trading 10.86% up at $9.10, versus its August 18 close of $8.21, with no clear August 19 company-specific catalyst identified.
- The latest indexed company material concerns second-quarter results and pipeline progress released August 6 and updated August 17.
- Broader markets are mixed, so the sharp move remains unexplained rather than clearly tied to sector or global sentiment.